From the David J. Apple Center for Vision Research, Department of Ophthalmology, University of Heidelberg, Heidelberg, Germany.
J Cataract Refract Surg. 2023 Feb 1;49(2):165-170. doi: 10.1097/j.jcrs.0000000000001064. Epub 2022 Oct 5.
To compare the enlargement of the clear corneal incision from IOL implantation with 2 different intraocular lens (IOL) injectors: the AutonoMe preloaded with the Clareon IOL and the Multisert preloaded with the Vivinex IOL.
The David J. Apple Center for Vision Research, Department of Ophthalmology, University of Heidelberg, Heidelberg, Germany.
Prospective randomized clinical comparative study.
96 eyes of 48 patients with cataract were intraindividually randomized to treatment with 1 of the 2 injectors. For Multisert eyes, the insert shield (IS) was used in the advanced position in 23 eyes. The initial incision was 2.2 mm, and intraoperative measurements of the incision size were made before and after IOL injection. 3 months postoperatively, keratometry and uncorrected (UDVA) and corrected (CDVA) distance visual acuities were assessed.
Results are reported for 96 eyes of 48 patients. The mean incision enlargement was 0.213 ± 0.068 mm in the Multisert with the IS group, 0.265 ± 0.055 mm in the fellow eyes (AutonoMe) ( P < .05), 0.272 ± 0.060 mm in Multisert eyes treated without the IS, and 0.296 ± 0.066 mm for the fellow eyes (AutonoMe) ( P > .05). The mean absolute surgically induced astigmatism was 0.42 ± 0.23 diopters (D), 0.50 ± 0.25 D, and 0.44 ± 0.18 D in the Multisert with the IS, Multisert without the IS, and AutonoMe group, respectively ( P > .05). The UDVA and CDVA were comparable in all groups.
The Multisert was associated with less wound enlargement than the AutonoMe. All groups had comparable functional outcomes. Therefore, the observed difference in incision enlargement may be of limited clinical relevance.
比较使用 2 种不同的眼内晶状体(IOL)注射器(预装 Clareon IOL 的 AutonoMe 和预装 Vivinex IOL 的 Multisert)进行 IOL 植入术后对透明角膜切口扩大的影响。
德国海德堡大学海德堡眼科的 David J. Apple 视觉研究中心。
前瞻性随机临床对照研究。
将 48 例白内障患者的 96 只眼分别随机分为 2 种注射器治疗组。对于 Multisert 眼,在 23 只眼中使用插入式保护罩(IS)的先进位置。初始切口为 2.2mm,在 IOL 注射前后进行切口大小的术中测量。术后 3 个月,评估角膜曲率、未矫正(UDVA)和矫正(CDVA)距离视力。
报告了 48 例患者的 96 只眼的结果。Multisert 带 IS 组的平均切口扩大为 0.213±0.068mm,对侧眼(AutonoMe)为 0.265±0.055mm(P<.05),Multisert 无 IS 治疗眼为 0.272±0.060mm,对侧眼(AutonoMe)为 0.296±0.066mm(P>.05)。Multisert 带 IS、Multisert 无 IS 和 AutonoMe 组的平均绝对手术诱导散光分别为 0.42±0.23 屈光度(D)、0.50±0.25D 和 0.44±0.18D(P>.05)。所有组的 UDVA 和 CDVA 均相当。
Multisert 与 AutonoMe 相比,切口扩大程度较小。所有组的功能结果相当。因此,观察到的切口扩大差异可能具有有限的临床意义。